BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23939238)

  • 1. Graves' disease as immune reconstitution disease in HIV-positive patients is associated with naive and primary thymic emigrant CD4(+) T-cell recovery.
    Sheikh V; Dersimonian R; Richterman AG; Porter BO; Natarajan V; Burbelo PD; Rupert A; Santich BH; Kardava L; Mican JM; Moir S; Sereti I
    AIDS; 2014 Jan; 28(1):31-9. PubMed ID: 23939238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis.
    Tan DB; Yong YK; Tan HY; Kamarulzaman A; Tan LH; Lim A; James I; French M; Price P
    HIV Med; 2008 May; 9(5):307-16. PubMed ID: 18400078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential occurrence of Graves' disease and immune thrombocytopenic purpura as manifestations of immune reconstitution inflammatory syndrome in an HIV-infected patient.
    Okazaki M; Nakamura M; Imai A; Asagiri T; Takeuchi S
    Int J STD AIDS; 2018 Jul; 29(8):834-836. PubMed ID: 29361886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graves' disease during immune reconstitution after highly active antiretroviral therapy for HIV infection: evidence of thymic dysfunction.
    French MA; Lewin SR; Dykstra C; Krueger R; Price P; Leedman PJ
    AIDS Res Hum Retroviruses; 2004 Feb; 20(2):157-62. PubMed ID: 15018703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graves' disease as an immune reconstitution syndrome in an HIV-1-positive patient commencing effective antiretroviral therapy: case report and literature review.
    Knysz B; Bolanowski M; Klimczak M; Gladysz A; Zwolinska K
    Viral Immunol; 2006; 19(1):102-7. PubMed ID: 16553555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and clinical relevance of circulating CD4+CD28- T cells in Graves' disease.
    Wang F; Chen L; Shen Q; Liu T; Jiang L; Gu X; Chen L; Sun J; Liu C
    Immunol Lett; 2015 May; 165(1):47-51. PubMed ID: 25839128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
    J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic Function during 12 Months of Highly Active Antiretroviral Therapy in Thai HIV-Infected Patients with Normal and Slow Immune Recovery.
    Kingkeow D; Srithep S; Praparattanapan J; Supparatpinyo K; Pornprasert S
    Jpn J Infect Dis; 2015; 68(5):353-6. PubMed ID: 25720642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated CD57 and CD95 expressions are associated with lower numbers of CD4⁺ recent thymic emigrants in HIV-1 infected immune responders following antiretroviral treatment.
    Lu I; Eberhard J; Ahmad F; Bhatnagar N; Behrens G; Jacobs R; Schmidt RE; Meyer-Olson D
    Immunol Lett; 2014; 158(1-2):1-6. PubMed ID: 24291117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TB-IRIS, T-cell activation, and remodeling of the T-cell compartment in highly immunosuppressed HIV-infected patients with TB.
    Haridas V; Pean P; Jasenosky LD; Madec Y; Laureillard D; Sok T; Sath S; Borand L; Marcy O; Chan S; Tsitsikov E; Delfraissy JF; Blanc FX; Goldfeld AE;
    AIDS; 2015 Jan; 29(3):263-73. PubMed ID: 25486415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients.
    Jubault V; Penfornis A; Schillo F; Hoen B; Izembart M; Timsit J; Kazatchkine MD; Gilquin J; Viard JP
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4254-7. PubMed ID: 11095463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated presentation of Graves' disease as a manifestation of immune reconstitution syndrome in an HIV-infected patient taking HAART: case report.
    Visković K; Stemberger L; Brnić Z; Begovac J
    Acta Clin Croat; 2013 Mar; 52(1):125-7. PubMed ID: 23837283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease.
    Tan DB; Lim A; Yong YK; Ponnampalavanar S; Omar S; Kamarulzaman A; French MA; Price P
    AIDS; 2011 Jul; 25(12):1455-60. PubMed ID: 21610488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
    Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR
    J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.
    Marchetti G; Gori A; Casabianca A; Magnani M; Franzetti F; Clerici M; Perno CF; Monforte Ad; Galli M; Meroni L
    AIDS; 2006 Aug; 20(13):1727-36. PubMed ID: 16931937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graves' immune reconstitution inflammatory syndrome in childhood.
    Sinha A; Abinun M; Gennery AR; Barge D; Slatter M; Cheetham T
    Thyroid; 2013 Aug; 23(8):1010-4. PubMed ID: 23556479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody and markers of T-cell activation illuminate the pathogenesis of HCV immune restoration disease in HIV/HCV co-infected patients commencing ART.
    Yunihastuti E; Lee S; Gani RA; Saraswati H; Sundaru H; Lesmana LA; Sukmana N; Price P
    Clin Immunol; 2011 Apr; 139(1):32-9. PubMed ID: 21296026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short communication: CD4 cell count increases during successful treatment of Graves' disease with methimazole in HIV-infected patients on antiretroviral therapy.
    Honda A; Kashiwazaki K; Tsunoda T; Gallant JE; Brown TT
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1627-9. PubMed ID: 22632156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of recently activated, memory and naive lymphocyte T subsets in the peripheral blood of patients with Graves' disease and insulin-dependent diabetes mellitus.
    Kretowski A; Myśliwiec J; Turowski D; Wysocka J; Kinalska I
    Rocz Akad Med Bialymst; 1999; 44():226-34. PubMed ID: 10697437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological characterisation of an unmasking TB-IRIS case.
    Wilkinson KA; Meintjes G; Seldon R; Goliath R; Wilkinson RJ
    S Afr Med J; 2012 Mar; 102(6):512-7. PubMed ID: 22668952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.